Literature DB >> 18790640

Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.

Yunsong Tong1, Kent D Stewart, Sheela Thomas, Magdalena Przytulinska, Eric F Johnson, Vered Klinghofer, Joel Leverson, Owen McCall, Niru B Soni, Yan Luo, Nan-horng Lin, Thomas J Sowin, Vincent L Giranda, Thomas D Penning.   

Abstract

A series of isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones were synthesized as potent inhibitors against Pim-1 and Pim-2 kinases. The structure-activity-relationship studies started from a high-throughput screening hit and was guided by molecular modeling of inhibitors in the active site of Pim-1 kinase. Installing a hydroxyl group on the benzene ring of the core has the potential to form a key hydrogen bond interaction to the hinge region of the binding pocket and thus resulted in the most potent inhibitor, 19, with K(i) values at 2.5 and 43.5 nM against Pim-1 and Pim-2, respectively. Compound 19 also exhibited an activity profile with a high degree of kinase selectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790640     DOI: 10.1016/j.bmcl.2008.08.079

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  The Pim protein kinases regulate energy metabolism and cell growth.

Authors:  Zanna Beharry; Sandeep Mahajan; Marina Zemskova; Ying-Wei Lin; Baby G Tholanikunnel; Zuping Xia; Charles D Smith; Andrew S Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway.

Authors:  Ke Ren; Wei Zhang; Yujun Shi; Jianping Gong
Journal:  Pathol Oncol Res       Date:  2009-10-12       Impact factor: 3.201

Review 3.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

Review 4.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

5.  Pim-1 kinase as cancer drug target: An update.

Authors:  Yernar Tursynbay; Jinfu Zhang; Zhi Li; Tursonjan Tokay; Zhaxybay Zhumadilov; Denglong Wu; Yingqiu Xie
Journal:  Biomed Rep       Date:  2015-12-24

Review 6.  Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling.

Authors:  Kimberlee M Fischer; Christopher T Cottage; Mathias H Konstandin; Mirko Völkers; Mohsin Khan; Mark A Sussman
Journal:  J Mol Cell Cardiol       Date:  2011-01-19       Impact factor: 5.000

7.  Clinical and therapeutic relevance of PIM1 kinase in gastric cancer.

Authors:  Benedict Yan; Ee Xuan Yau; Sanjay Samanta; Chee Wee Ong; Kol Jia Yong; Lai Kuan Ng; Bhaskar Bhattacharya; Kiat Hon Lim; Richie Soong; Khay Guan Yeoh; Niantao Deng; Patrick Tan; Yulin Lam; Manuel Salto-Tellez
Journal:  Gastric Cancer       Date:  2011-10-13       Impact factor: 7.370

8.  Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach.

Authors:  Ashraf H Abadi; Dalal A Abouel-Ella; Jochen Lehmann; Heather N Tinsley; Bernard D Gary; Gary A Piazza; Mohammed A O Abdel-Fattah
Journal:  Eur J Med Chem       Date:  2009-09-20       Impact factor: 6.514

9.  Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.

Authors:  Pietro Ciceri; Susanne Müller; Alison O'Mahony; Oleg Fedorov; Panagis Filippakopoulos; Jeremy P Hunt; Elisabeth A Lasater; Gabriel Pallares; Sarah Picaud; Christopher Wells; Sarah Martin; Lisa M Wodicka; Neil P Shah; Daniel K Treiber; Stefan Knapp
Journal:  Nat Chem Biol       Date:  2014-03-02       Impact factor: 15.040

10.  Synthesis of 2,1-benzisoxazole-3(1H)-ones by base-mediated photochemical N-O bond-forming cyclization of 2-azidobenzoic acids.

Authors:  Daria Yu Dzhons; Andrei V Budruev
Journal:  Beilstein J Org Chem       Date:  2016-05-04       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.